The lungs have evolved to keep things out. Can these biotech stocks get drugs in?

Auris Medical says it will advance a treatment for colorectal cancer as its first therapeutic indication for a delivery platform.

Arrowhead's move comes after a toxicology study in rats contained unexpected signals of local lung inflammation, the company says.

Jim Cramer says it seems we're in disarray, and we are. But investors need to keep a sharp eye out for a rebound on the horizon.

Arrowhead Pharma, Kodak, AMC Networks, Cornerstone Building Brands, and Inovio Pharma are some of the top gainers for Wednesday.

Stocks may be down, says Jim Cramer, but it's more about the administration getting tough on China again than it is a weakening economy.

Jim Cramer has a list of 12 presents he'd love to see investors get this holiday season, from a prosperous stock market to a true resolution of the trade wars in the coming year.

Impeachment, trade and tariffs, the yield curve, even the opioid crisis -- Jim Cramer explains why this bull is just trampling these obstacles.

Jim Cramer takes a look at FedEx, Synopsys, Autodesk, Grocery Outlet, Arrowhead Pharmaceuticals and more.

"We're seeing customers continue to invest along with macroeconomic tailwinds," said CEO Peter Arduini.

Southwest Airlines has some major problems and passengers may be wary of flying the airline, but its current problems don't tell the whole story.

A major change is coming to Sin City's iconic 4.2-mile road, but maybe not in the way most people expected.